BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 2, 2009
View Archived Issues
In vivo profile of K-056, a new adenosine A2A antagonist
Read More
12-month COMET-1 results show efficacy of CRx-102 in knee osteoarthritis
Read More
ADL-5510 reduces levodopa-induced dyskinesia in macaque model of PD
Read More
CP-8947, a novel nonsteroidal SPRM, exhibits progestational activity in preclinical study
Read More
New antiproliferative compounds disclosed by the European Molecular Biology Laboratory
Read More
Abeta production inhibitors claimed by Eisai for the treatment of Alzheimer's disease
Read More
Advaxis receives IRB approval for ADXS-11-001 trial in cervical dysplasia
Read More
ARYx Therapeutics prepares to outlicense budiodarone, ATI-7505 and tecarfarin
Read More
MAP Pharmaceuticals completes interim safety review of phase III Levadex trial
Read More
FDA grants emergency use authorization to Gen-Probe's Prodesse ProFlu-ST test for H1N1 flu
Read More
Pharmaxis files MAA with EMEA for Bronchitol in cystic fibrosis
Read More
FDA issues complete response letter regarding Transcept's NDA for Intermezzo
Read More
NasVax reports results from preclinical testing of H1N1 antigen formulated with VaxiSome
Read More
Ipsen launches Dysport in U.S. for treatment of cervical dystonia in adults
Read More
Eisai and Quintiles sign strategic collaboration agreement to develop six oncology drugs
Read More
Health Canada grants product approval for Intercell's Japanese encephalitis vaccine Ixiaro
Read More
Novartis Pharma decides not to license Idenix's IDX-184 for hepatitis C
Read More
Phase III trial evaluates effects of tolvaptan on kidney volume change in ADPKD
Read More
Everolimus/EC-MPS improves renal function in de novo renal transplant patients
Read More
Human data available for anti-obesity drug PSN-602
Read More
TVPR1 antagonists described by sanofi-aventis as analgesics
Read More
Genta reports results from phase III AGENDA trial of Genasense in advanced melanoma
Read More
Shire reports results from study of selective alpha-2A agonist Intuniv for ADHD
Read More
Celldex Therapeutics reports results from phase I studies of CDX-1307 in advanced epithelial cancers
Read More
Hutchison MediPharma starts phase I trial of HMPL-011 for auto-immune disease
Read More